Product Information
DARUNAVIR 600 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $1.1628 per EA under NDC 76282073760. Its NADAC has been published 130 times since Apr 10, 2024.
FDA first approved this application on Nov 28, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282073760
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DARUNAVIR HYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA206288FDA Approved
11/28/2023
TE Code
AB
On Market Since
1/19/2024
Pharmacological Classes
Price Statistics
The NADAC for DARUNAVIR 600 MG TABLET has been published 130 times since Apr 10, 2024, and over the history we have for it it has declined 36.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1628 per EA |
|---|---|
| All-time high | $1.8327 (Apr 10, 2024) |
| All-time low | $1.1309 (Mar 18, 2026) |
| 52-week high | $1.2126 |
| 52-week low | $1.1309 |
| Median price | $1.2246 |
| Average price | $1.3422 |
| Largest weekly change | -10.1% (Jun 19, 2024) |
| Weeks tracked | 130 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the darunavir 600 mg market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Exelan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
darunavir 600 mg market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Protease Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DARUNAVIR 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DARUNAVIR 600 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $1.1628 per EA (NDC 76282073760), effective Sep 30, 2026.
How has the price of DARUNAVIR 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for DARUNAVIR 600 MG TABLET has declined 36.6%. It has been tracked across 130 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for DARUNAVIR 600 MG TABLET?
Since Apr 10, 2024, the NADAC for DARUNAVIR 600 MG TABLET has ranged from a low of $1.1309 (Mar 18, 2026) to a high of $1.8327 (Apr 10, 2024), with a median of $1.2246 per EA.
Are there cheaper alternatives to DARUNAVIR 600 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DARUNAVIR 600 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DARUNAVIR 600 MG TABLET?
DARUNAVIR 600 MG TABLET (NDC 76282073760) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.